MICROZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Microzide, and when can generic versions of Microzide launch?
Microzide is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in MICROZIDE is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Microzide
A generic version of MICROZIDE was approved as hydrochlorothiazide by UNICHEM on August 15th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MICROZIDE?
- What are the global sales for MICROZIDE?
- What is Average Wholesale Price for MICROZIDE?
Summary for MICROZIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 4 |
| Patent Applications: | 3,761 |
| DailyMed Link: | MICROZIDE at DailyMed |
Recent Clinical Trials for MICROZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of New Mexico | Early Phase 1 |
| University of Pittsburgh | Early Phase 1 |
| Dialysis Clinic, Inc. | Early Phase 1 |
US Patents and Regulatory Information for MICROZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | MICROZIDE | hydrochlorothiazide | CAPSULE;ORAL | 020504-001 | Dec 27, 1996 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
